Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
426 Ergebnisse
| GW4NAT | Vertex Pharmaceuticals Inc./OS/Call [460]/GOLDS | - | - | 460,000 | call | Vertex Pharmaceuticals Inc. | - | 39,122 % | 0,646 | -0,078 | 3,609 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW4RBE | Vertex Pharmaceuticals Inc./OS/Call [460]/GOLDS | - | - | 460,000 | call | Vertex Pharmaceuticals Inc. | - | 38,934 % | 0,652 | -0,104 | 4,611 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GW4WHG | Vertex Pharmaceuticals Inc./OS/Call [460]/GOLDS | - | - | 460,000 | call | Vertex Pharmaceuticals Inc. | - | 39,837 % | 0,634 | -0,092 | 4,087 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| JH5U1B | Vertex Pharmaceuticals Inc./OS/Call [460]/JPM | - | - | 460,000 | call | Vertex Pharmaceuticals Inc. | - | 41,961 % | 0,618 | -0,185 | 7,286 | 18.09.2026 | 0,100 | JP Morgan | ||
| JH5SJH | Vertex Pharmaceuticals Inc./OS/Call [460]/JPM | - | - | 460,000 | call | Vertex Pharmaceuticals Inc. | - | 40,859 % | 0,623 | -0,117 | 4,926 | 18.12.2026 | 0,100 | JP Morgan | ||
| JH9BES | Vertex Pharmaceuticals Inc./OS/Call [460]/JPM | - | - | 460,000 | call | Vertex Pharmaceuticals Inc. | - | 41,375 % | 0,627 | -0,109 | 4,522 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE11YR | Vertex Pharmaceuticals Inc./OS/Call [460]/JPMD | - | - | 460,000 | call | Vertex Pharmaceuticals Inc. | - | 43,241 % | 0,634 | -0,098 | 3,829 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE9DHR | Vertex Pharmaceuticals Inc./OS/Call [460]/JPMD | - | - | 460,000 | call | Vertex Pharmaceuticals Inc. | - | 42,186 % | 0,646 | -0,083 | 3,406 | 17.06.2027 | 0,100 | JP Morgan | ||
| SX5K5C | Vertex Pharmaceuticals Inc./OS/Call [460]/SOC | - | - | 460,000 | call | Vertex Pharmaceuticals Inc. | - | 41,385 % | 0,624 | -0,109 | 4,533 | 15.01.2027 | 0,100 | Société Générale | ||
| FD1YTN | Vertex Pharmaceuticals Inc./OS/Call [460]/SOC | - | - | 460,000 | call | Vertex Pharmaceuticals Inc. | - | 43,225 % | 0,613 | -0,190 | 7,135 | 18.09.2026 | 0,100 | Société Générale | ||
| FE1AXP | Vertex Pharmaceuticals Inc./OS/Call [460]/SOC | - | - | 460,000 | call | Vertex Pharmaceuticals Inc. | - | 41,357 % | 0,621 | -0,118 | 4,889 | 18.12.2026 | 0,100 | Société Générale | ||
| FE1AXU | Vertex Pharmaceuticals Inc./OS/Call [460]/SOC | - | - | 460,000 | call | Vertex Pharmaceuticals Inc. | - | 42,556 % | 0,635 | -0,096 | 3,873 | 19.03.2027 | 0,100 | Société Générale | ||
| FE58UZ | Vertex Pharmaceuticals Inc./OS/Call [460]/SOC | - | - | 460,000 | call | Vertex Pharmaceuticals Inc. | - | 41,440 % | 0,646 | -0,082 | 3,454 | 17.06.2027 | 0,100 | Société Générale | ||
| FE58VG | Vertex Pharmaceuticals Inc./OS/Call [460]/SOC | - | - | 460,000 | call | Vertex Pharmaceuticals Inc. | - | 41,205 % | 0,666 | -0,063 | 2,819 | 21.01.2028 | 0,100 | Société Générale | ||
| JH5U1N | Vertex Pharmaceuticals Inc./OS/Call [470]/JPM | - | - | 470,000 | call | Vertex Pharmaceuticals Inc. | - | 42,394 % | 0,570 | -0,191 | 7,615 | 18.09.2026 | 0,100 | JP Morgan | ||
| JH5SJS | Vertex Pharmaceuticals Inc./OS/Call [470]/JPM | - | - | 470,000 | call | Vertex Pharmaceuticals Inc. | - | 41,268 % | 0,590 | -0,119 | 5,066 | 18.12.2026 | 0,100 | JP Morgan | ||
| JH9BET | Vertex Pharmaceuticals Inc./OS/Call [470]/JPM | - | - | 470,000 | call | Vertex Pharmaceuticals Inc. | - | 41,695 % | 0,599 | -0,111 | 4,626 | 15.01.2027 | 0,100 | JP Morgan | ||
| MM215V |  | Vertex Pharmaceuticals Inc./OS/Call [475]/MS | - | - | 475,000 | call | Vertex Pharmaceuticals Inc. | - | 41,131 % | 0,574 | -0,012 | 5,165 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MM215U | | Vertex Pharmaceuticals Inc./OS/Call [475]/MS | - | - | 475,000 | call | Vertex Pharmaceuticals Inc. | - | 42,226 % | 0,617 | -0,008 | 3,508 | 17.06.2027 | 0,010 | Morgan Stanley | |
| GW3T4J | Vertex Pharmaceuticals Inc./OS/Call [480]/GOLDS | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 38,367 % | 0,593 | -0,106 | 4,981 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GW3T6M | Vertex Pharmaceuticals Inc./OS/Call [480]/GOLDS | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 39,162 % | 0,583 | -0,092 | 4,371 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW5276 | Vertex Pharmaceuticals Inc./OS/Call [480]/GOLDS | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 38,361 % | 0,602 | -0,079 | 3,838 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| JH3B3B | Vertex Pharmaceuticals Inc./OS/Call [480]/JPM | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 41,343 % | 0,568 | -0,111 | 4,817 | 15.01.2027 | 0,100 | JP Morgan | ||
| JH5U1L | Vertex Pharmaceuticals Inc./OS/Call [480]/JPM | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 42,351 % | 0,520 | -0,191 | 8,049 | 18.09.2026 | 0,100 | JP Morgan | ||
| JH5SJJ | Vertex Pharmaceuticals Inc./OS/Call [480]/JPM | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 40,775 % | 0,587 | -0,120 | 5,116 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE05DK | Vertex Pharmaceuticals Inc./OS/Call [480]/JPMD | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 39,616 % | 0,533 | -0,149 | 7,065 | 16.10.2026 | 0,100 | JP Morgan | ||
| JE11YT | Vertex Pharmaceuticals Inc./OS/Call [480]/JPMD | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 42,796 % | 0,585 | -0,098 | 4,061 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE81LQ | Vertex Pharmaceuticals Inc./OS/Call [480]/JPMD | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 42,034 % | 0,604 | -0,084 | 3,566 | 17.06.2027 | 0,100 | JP Morgan | ||
| JY32WF | Vertex Pharmaceuticals Inc./OS/Call [480]/JPMD | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 45,556 % | 0,490 | -0,285 | 10,505 | 21.08.2026 | 0,100 | JP Morgan | ||
| SX5K5D | Vertex Pharmaceuticals Inc./OS/Call [480]/SOC | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 40,661 % | 0,570 | -0,109 | 4,871 | 15.01.2027 | 0,100 | Société Générale | ||
| FE1AXK | Vertex Pharmaceuticals Inc./OS/Call [480]/SOC | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 41,728 % | 0,520 | -0,189 | 8,153 | 18.09.2026 | 0,100 | Société Générale | ||
| FE4XZ2 | Vertex Pharmaceuticals Inc./OS/Call [480]/SOC | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 39,508 % | 0,586 | -0,117 | 5,259 | 18.12.2026 | 0,100 | Société Générale | ||
| FE58HH | Vertex Pharmaceuticals Inc./OS/Call [480]/SOC | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 41,695 % | 0,607 | -0,098 | 4,050 | 19.03.2027 | 0,100 | Société Générale | ||
| FE58U0 | Vertex Pharmaceuticals Inc./OS/Call [480]/SOC | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 40,980 % | 0,603 | -0,082 | 3,641 | 17.06.2027 | 0,100 | Société Générale | ||
| FE58VH | Vertex Pharmaceuticals Inc./OS/Call [480]/SOC | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 40,232 % | 0,634 | -0,063 | 2,960 | 21.01.2028 | 0,100 | Société Générale | ||
| VH625G | | Vertex Pharmaceuticals Inc./OS/Call [480]/VONT | - | - | 480,000 | call | Vertex Pharmaceuticals Inc. | - | 38,819 % | 0,567 | -0,105 | 5,080 | 15.01.2027 | 0,100 | Vontobel | |
| JH3B3A | Vertex Pharmaceuticals Inc./OS/Call [490]/JPM | - | - | 490,000 | call | Vertex Pharmaceuticals Inc. | - | 41,193 % | 0,542 | -0,111 | 4,961 | 15.01.2027 | 0,100 | JP Morgan | ||
| JH5VLU | Vertex Pharmaceuticals Inc./OS/Call [490]/JPM | - | - | 490,000 | call | Vertex Pharmaceuticals Inc. | - | 40,791 % | 0,511 | -0,187 | 8,340 | 18.09.2026 | 0,100 | JP Morgan | ||
| JH5SJG | Vertex Pharmaceuticals Inc./OS/Call [490]/JPM | - | - | 490,000 | call | Vertex Pharmaceuticals Inc. | - | 40,750 % | 0,529 | -0,118 | 5,455 | 18.12.2026 | 0,100 | JP Morgan | ||
| GJ8ZUS | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 36,555 % | 0,518 | -0,110 | 6,036 | 18.12.2026 | 0,100 | Goldman Sachs | ||
| GV0K08 | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 37,668 % | 0,532 | -0,105 | 5,387 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GV70J6 | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 36,308 % | 0,400 | -0,158 | 10,511 | 18.09.2026 | 0,100 | Goldman Sachs | ||
| GV87PB | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 37,902 % | 0,577 | -0,080 | 3,969 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW01DL | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 40,430 % | 0,603 | -0,064 | 3,040 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| GW1W1X | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 38,899 % | 0,532 | -0,092 | 4,630 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW85MB | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 34,570 % | 0,428 | -0,128 | 8,914 | 16.10.2026 | 0,100 | Goldman Sachs | ||
| GW8MX4 | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 40,592 % | 0,353 | -0,232 | 13,557 | 21.08.2026 | 0,100 | Goldman Sachs | ||
| JZ6TNH | Vertex Pharmaceuticals Inc./OS/Call [500]/JPMD | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 40,971 % | 0,513 | -0,110 | 5,130 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE04W2 | Vertex Pharmaceuticals Inc./OS/Call [500]/JPMD | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 43,291 % | 0,426 | -0,189 | 8,709 | 18.09.2026 | 0,100 | JP Morgan | ||
| JE0B5K | Vertex Pharmaceuticals Inc./OS/Call [500]/JPMD | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 40,138 % | 0,488 | -0,152 | 7,286 | 16.10.2026 | 0,100 | JP Morgan |